Settlement Between Pfizer and Teva on Generic Zyvox is a Significant Positive for Trius TherapeuticsMonday, October 29, 2012 · 10:43 am |
|
Generic Challenge to Pfizer's EpiPen by Teva and Antares (AIS, $2.70)Sunday, April 8, 2012 · 11:44 am |
|
Initiation Report on a Cheap Lumbering Stock (PFE, $20.78)Thursday, May 5, 2011 · 1:31 pm |
|
There are 3 reports on file. |